Related Experiment Video
Updated: Jan 27, 2026

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3
Published on: December 27, 2010
Deciphering Endothelial Dysfunction in the HIV-Infected Population
Genevieve Mezoh1, Nigel J Crowther2,3
1Department of Chemical Pathology, University of the Witwatersrand Faculty of Health Sciences, Johannesburg, South Africa. mezohg@yahoo.fr.
Insights
Assessing endothelial function is crucial for HIV patients at risk of cardiovascular disease (CVD). This review explores non-invasive methods and blood biomarkers for early CVD detection in HIV.
Area of Science:
- Cardiology
- Infectious Diseases
- Biomarker Discovery
Background:
- Cardiovascular disease (CVD) is a significant concern for HIV-infected individuals, even with effective antiretroviral therapy.
- Endothelial dysfunction is a key factor contributing to CVD in this population.
- Current methods for assessing endothelial function in HIV patients lack consistency.
Purpose of the Study:
- To review current non-invasive techniques for evaluating endothelial function in HIV-infected patients.
- To highlight promising blood-based biomarkers for assessing endothelial dysfunction.
- To emphasize the need for accessible diagnostic tools in resource-limited settings.
Main Methods:
- Systematic review of non-invasive endothelial function assessment strategies.
- Analysis of proposed blood-based biomarkers including E-selectin, sICAM-1, sVCAM-1, vWF, TNF-α, IL6, and sTM.
- Focus on biomarkers suitable for point-of-care testing.
Main Results:
- Various non-invasive methods exist for assessing endothelial function, but results can be inconsistent.
- Several blood biomarkers show potential for indicating endothelial dysfunction in HIV.
- Point-of-care assays for these biomarkers could improve CVD risk assessment.
Conclusions:
- Routine assessment of endothelial function is recommended for HIV patients to mitigate CVD risk.
- Development of reliable blood-based biomarkers is essential for early detection and management.
- Point-of-care testing offers a viable solution for widespread application, particularly in high HIV prevalence regions.
Abstract:
Cardiovascular disease (CVD), as a possible consequence of endothelial dysfunction, is prevalent among HIV-infected patients despite successful administration of antiretroviral drugs. This warrants the routine clinical assessment of endothelial function in HIV-positive patients to circumvent potential CVD events. Several different non-invasive strategies have been employed to assess endothelial function in clinical research studies yielding inconsistencies among these reports. This review summarises the different techniques used for assessing endothelial function, with a focus on proposed blood-based biomarkers, such as endothelial leukocyte adhesion molecule-1 (E-selectin), soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1 (sVCAM-1), von Willebrand factor (vWF), TNF-α, interleukin 6 (IL6) and soluble thrombomodulin (sTM). The identification of suitable blood-based biomarkers, especially those that can be measured using a point-of-care device, would be more applicable in under-resourced countries where the prevalence of HIV is high.
More Related Videos
Related Concept Videos
Conservation of Small Populations
What is Population Genetics?
Population Growth
What are Populations and Communities?
Conservation of Declining Populations
Testing a Claim about Mean: Known Population SD
Estimating a population mean requires the samples to be distributed normally. The data should be collected from the randomly selected samples having no sampling bias. The sample size needed to be higher than 30, and most importantly, the population standard deviation should be already known.
In most realistic situations, the population standard deviation is often unknown, but in rare circumstances, when it...

